Fortis Healthcare Ltd

Fortis Health. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fortis Healthcare Ltd

₹ 672 -1.05%
21 May - close price
fortishealthcare.com BSE: 532843 NSE: FORTIS
About

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]

Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

Key Points

Business Segments [1]
a) Hospital Segment: Co. operates Multi-specialty and super-speciality hospitals providing inpatient and outpatient treatments across various disciplines.

Website BSE NSE
  • Market Cap ₹ 50,737 Cr.
  • Current Price ₹ 672
  • High / Low ₹ 744 / 406
  • Stock P/E 60.2
  • Book Value ₹ 118
  • Dividend Yield 0.15 %
  • ROCE 12.0 %
  • ROE 10.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 70.4% CAGR over last 5 years

Cons

  • Stock is trading at 5.69 times its book value
  • The company has delivered a poor sales growth of 10.9% over past five years.
  • Company has a low return on equity of 8.68% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Alpha 50

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,378 1,488 1,607 1,560 1,643 1,657 1,770 1,680 1,786 1,859 1,988 1,928 2,007
1,157 1,237 1,304 1,283 1,372 1,386 1,440 1,396 1,405 1,516 1,554 1,553 1,572
Operating Profit 221 251 303 276 271 272 330 284 381 343 435 375 435
OPM % 16% 17% 19% 18% 16% 16% 19% 17% 21% 18% 22% 19% 22%
13 31 75 26 26 10 18 19 17 14 -42 47 -29
Interest 30 31 33 33 32 31 32 33 35 35 36 45 68
Depreciation 77 74 77 83 82 79 84 87 92 91 95 97 102
Profit before tax 126 176 268 186 183 171 233 183 271 230 261 279 237
Tax % 31% 24% 19% 24% 25% 27% 21% 27% 25% 24% 26% 9% 21%
87 134 218 142 138 124 184 134 203 174 193 254 188
EPS in Rs 0.90 1.62 2.71 1.72 1.76 1.48 2.30 1.78 2.37 2.20 2.34 3.28 2.44
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3,492 3,966 4,199 4,574 4,561 4,469 4,632 4,030 5,718 6,298 6,893 7,783
3,430 3,857 4,106 4,220 4,287 4,238 4,022 3,626 4,649 5,196 5,625 6,195
Operating Profit 62 109 92 354 274 231 610 404 1,069 1,101 1,268 1,588
OPM % 2% 3% 2% 8% 6% 5% 13% 10% 19% 17% 18% 20%
152 92 299 649 -689 228 126 95 367 157 64 -11
Interest 250 152 133 229 258 337 205 166 147 129 131 184
Depreciation 183 235 225 222 239 233 292 291 301 316 342 386
Profit before tax -219 -185 34 552 -912 -110 239 43 988 814 858 1,007
Tax % 5% 2% -24% 13% 2% 103% 62% 230% 20% 22% 25% 20%
-218 -130 42 479 -934 -224 91 -56 790 633 645 809
EPS in Rs -4.73 -3.10 0.40 8.14 -19.46 -3.96 0.77 -1.45 7.35 7.80 7.93 10.26
Dividend Payout % -0% -1% 0% 0% 0% 0% 0% 0% 0% 13% 13% 10%
Compounded Sales Growth
10 Years: 7%
5 Years: 11%
3 Years: 11%
TTM: 13%
Compounded Profit Growth
10 Years: 24%
5 Years: 70%
3 Years: 31%
TTM: 44%
Stock Price CAGR
10 Years: 15%
5 Years: 43%
3 Years: 41%
1 Year: 43%
Return on Equity
10 Years: 4%
5 Years: 7%
3 Years: 9%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 463 463 463 518 519 755 755 755 755 755 755 755
Reserves 3,820 3,585 3,998 4,626 3,543 5,846 5,906 5,365 5,423 6,487 6,908 8,162
2,550 1,784 1,513 2,217 1,962 2,010 1,594 1,531 1,255 926 1,155 2,475
1,018 1,760 1,257 2,227 2,455 2,875 2,781 3,216 4,082 3,921 4,153 2,300
Total Liabilities 7,851 7,592 7,232 9,588 8,479 11,486 11,036 10,866 11,516 12,089 12,971 13,692
4,147 4,218 3,642 5,419 4,992 8,477 8,802 8,799 9,416 9,426 9,874 10,426
CWIP 147 228 226 268 226 450 204 165 193 228 542 404
Investments 1,817 1,464 1,452 1,878 1,732 270 175 186 104 210 230 169
1,739 1,682 1,913 2,023 1,529 2,290 1,856 1,716 1,803 2,225 2,326 2,692
Total Assets 7,851 7,592 7,232 9,588 8,479 11,486 11,036 10,866 11,516 12,089 12,971 13,692

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
479 24 195 966 493 -179 172 485 865 822 1,100 1,424
2,503 213 122 -1,001 -333 -3,279 63 -131 -501 -372 -889 -779
-3,217 -304 -354 259 -672 4,257 -862 -143 -517 -471 -86 -714
Net Cash Flow -235 -66 -37 225 -513 799 -627 212 -153 -21 125 -69

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 46 38 39 38 38 44 36 41 33 34 33 37
Inventory Days 26 25 23 23 24 22 30 29 33 31 24 23
Days Payable 200 207 218 215 279 296 226 205 178 179 164 161
Cash Conversion Cycle -128 -144 -156 -155 -217 -230 -161 -135 -112 -115 -107 -101
Working Capital Days -16 -69 -24 -33 -76 -133 -116 -37 -21 -12 -115 -23
ROCE % 0% -0% 3% 11% 3% 6% 4% 2% 10% 10% 10% 12%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17%
29.66% 30.59% 31.01% 31.22% 30.03% 26.31% 23.72% 23.24% 23.31% 25.26% 26.77% 27.40%
17.60% 20.02% 20.38% 20.69% 22.17% 26.55% 29.42% 31.14% 32.31% 30.73% 30.05% 29.46%
21.57% 18.22% 17.44% 16.92% 16.65% 15.97% 15.71% 14.44% 13.22% 12.83% 12.02% 11.98%
No. of Shareholders 1,60,7621,58,4551,43,5191,37,8941,35,0471,31,5161,35,6641,57,1651,54,2602,04,1842,21,7502,18,329

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls